These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 11490173

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Increased [3H] raclopride binding sites in postmortem brains from schizophrenic violent suicide victims.
    Ruiz J, Gabilondo AM, Meana JJ, García-Sevilla JA.
    Psychopharmacology (Berl); 1992; 109(4):410-4. PubMed ID: 1365855
    [Abstract] [Full Text] [Related]

  • 5. Caudate nucleus dopamine d(2) receptors in vascular dementia.
    Allard P, Englund E, Marcusson J.
    Dement Geriatr Cogn Disord; 2002; 14(1):22-5. PubMed ID: 12053128
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Relation of dopamine receptor 2 binding to pain perception in female fibromyalgia patients with and without depression--A [¹¹C] raclopride PET-study.
    Ledermann K, Jenewein J, Sprott H, Hasler G, Schnyder U, Warnock G, Johayem A, Kollias S, Buck A, Martin-Soelch C.
    Eur Neuropsychopharmacol; 2016 Feb; 26(2):320-330. PubMed ID: 26708319
    [Abstract] [Full Text] [Related]

  • 8. D2 receptor binding in dopa-responsive dystonia.
    Künig G, Leenders KL, Antonini A, Vontobel P, Weindl A, Meinck HM.
    Ann Neurol; 1998 Nov; 44(5):758-62. PubMed ID: 9818931
    [Abstract] [Full Text] [Related]

  • 9. Dopamine D2 receptor binding in drug-naïve patients with schizophrenia examined with raclopride-C11 and positron emission tomography.
    Talvik M, Nordström AL, Okubo Y, Olsson H, Borg J, Halldin C, Farde L.
    Psychiatry Res; 2006 Dec 01; 148(2-3):165-73. PubMed ID: 17095199
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Rostrocaudal gradients of dopamine D2/3 receptor binding in striatal subregions measured with [(11)C]raclopride and high-resolution positron emission tomography.
    Alakurtti K, Johansson JJ, Tuokkola T, Någren K, Rinne JO.
    Neuroimage; 2013 Nov 15; 82():252-9. PubMed ID: 23727314
    [Abstract] [Full Text] [Related]

  • 17. Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride.
    Antonini A, Schwarz J, Oertel WH, Pogarell O, Leenders KL.
    Mov Disord; 1997 Jan 15; 12(1):33-8. PubMed ID: 8990051
    [Abstract] [Full Text] [Related]

  • 18. Mu-receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in man.
    Hagelberg N, Kajander JK, Någren K, Hinkka S, Hietala J, Scheinin H.
    Synapse; 2002 Jul 15; 45(1):25-30. PubMed ID: 12112410
    [Abstract] [Full Text] [Related]

  • 19. Recovery of dopamine transporters with methamphetamine detoxification is not linked to changes in dopamine release.
    Volkow ND, Wang GJ, Smith L, Fowler JS, Telang F, Logan J, Tomasi D.
    Neuroimage; 2015 Nov 01; 121():20-8. PubMed ID: 26208874
    [Abstract] [Full Text] [Related]

  • 20. Dopamine D2 and D3 receptors in human putamen, caudate nucleus, and globus pallidus.
    Seeman P, Wilson A, Gmeiner P, Kapur S.
    Synapse; 2006 Sep 01; 60(3):205-11. PubMed ID: 16739118
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.